1. Home
  2. ATLX vs KPTI Comparison

ATLX vs KPTI Comparison

Compare ATLX & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlas Lithium Corporation

ATLX

Atlas Lithium Corporation

HOLD

Current Price

$5.21

Market Cap

105.7M

Sector

Industrials

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.78

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLX
KPTI
Founded
2011
2008
Country
Brazil
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.7M
139.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ATLX
KPTI
Price
$5.21
$8.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$12.00
$22.17
AVG Volume (30 Days)
635.0K
315.7K
Earning Date
11-13-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,454.00
$142,530,000.00
Revenue This Year
$22,084.55
$3.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$3.51
52 Week High
$8.25
$11.55

Technical Indicators

Market Signals
Indicator
ATLX
KPTI
Relative Strength Index (RSI) 59.43 75.48
Support Level $4.77 $7.01
Resistance Level $5.33 $7.44
Average True Range (ATR) 0.36 0.47
MACD 0.11 0.10
Stochastic Oscillator 91.00 84.26

Price Performance

Historical Comparison
ATLX
KPTI

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: